pentamidine has been researched along with naphthoquinones in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (68.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, WT | 1 |
| Caldwell, PT; Deresinski, SC; Dohn, MN; Follansbee, SE; Gathe, JC; Haghighat, DP; Lancaster, DJ; Meyer, RD; Sampson, JH; Scott, JD; Spotkov, J; Torres, RA; Weinberg, WG | 1 |
| Hughes, WT; Killmar, JT; Oz, HS | 1 |
| Kovacs, JA; Martinez, A | 1 |
| Bogner, JR; Goebel, FD | 1 |
| Korraa, H; Saadeh, C | 1 |
| Deresinski, SC | 1 |
| Fishman, JA | 2 |
| Holmberg, SD; Moorman, AC; Palella, FJ; Von Bargen, JC | 1 |
| Bryan, E; McFarland, J; Sackoff, J; Su, S | 1 |
| Castro, M | 1 |
| Bala, MV; Bennett, CL; Dohn, MN; Simpson, K; Wood, LL; Zarkin, GA | 1 |
| Caldwell, P; Chan, C; Dohn, M; Lefebvre, EA; Marina, R; McIvor, RA; Montaner, J; Morey, G; Scott, J | 1 |
| Gray, JS; Pudney, M | 1 |
| Collins, M; Cushion, MT; Hazra, B; Kaneshiro, ES | 1 |
| Cadman, J; Torres, G | 1 |
| Groll, AH; Müller, FM; Ritter, J | 1 |
| Gill, VJ; Kovacs, JA; Masur, H; Meshnick, S | 1 |
| Cohen, CJ; Craven, DE; Freedberg, KA; Goldie, SJ; Kaplan, JE; Kimmel, AD; Losina, E; Paltiel, AD; Seage, GR; Weinstein, MC; Zhang, H | 1 |
| Bellamy, R | 2 |
| Barreto, RF; Batista, DG; Batista, MM; Boykin, DW; Castro, SL; Daliry, A; Dantas, AP; de Souza, EM; Oliveira, GM; Pacheco, MG; Salomão, K; Santa-Rita, RM; Silva, CF; Silva, PB; Soeiro, Mde N | 1 |
| Alexandre-Moreira, MS; Camara, CA; da Silva, JK; da Silva, KC; David, CC; de A Brandão, VB; de Araújo, MV; de Oliveira, LA; Dos Santos, JM; Neto, JC; Silva, TM | 1 |
10 review(s) available for pentamidine and naphthoquinones
| Article | Year |
|---|---|
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Cohort Studies; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Rats; Tablets; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
[Therapy and prevention of pneumocystis carinii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Dapsone; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Humans; Leucovorin; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1996 |
Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Humans; Infusions, Intravenous; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1997 |
Prevention of infection due to Pneumocystis carinii.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Fungal Vaccines; Humans; Microbial Sensitivity Tests; Naphthoquinones; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Treatment of infection due to Pneumocystis carinii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans; Macrolides; Naphthoquinones; Pentamidine; Pneumocystis; Pneumocystis Infections; Pneumonia, Pneumocystis; Pyrimidines; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1998 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clinical Trials as Topic; Dapsone; Female; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Prognosis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Naphthoquinones; Neoplasms; Odds Ratio; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Pneumocystis carinii pneumonia treatment in people infected with HIV.
Topics: Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Pneumocystis pneumonia in people with HIV.
Topics: Atovaquone; Clindamycin; Corticosterone; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
5 trial(s) available for pentamidine and naphthoquinones
| Article | Year |
|---|---|
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Cohort Studies; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Rats; Tablets; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Survival Analysis; Treatment Outcome | 1994 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service | 1998 |
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia.
Topics: Antifungal Agents; Atovaquone; Costs and Cost Analysis; Decision Trees; Humans; Injections, Intravenous; Monte Carlo Method; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis | 1996 |
Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim | 1999 |
11 other study(ies) available for pentamidine and naphthoquinones
| Article | Year |
|---|---|
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Development and characterization of a rapid screening assay for identifying antipneumocystis agents.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cell Membrane Permeability; Fungal Proteins; Membrane Glycoproteins; Methionine; Microbial Sensitivity Tests; Naphthoquinones; Pentamidine; Pneumocystis; Precipitin Tests; Sulfur Radioisotopes; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha | 1993 |
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Morbidity; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 1998 |
Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chronic Disease; Clindamycin; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Gerbillinae; Humans; Imidocarb; Naphthoquinones; Pentamidine; Recurrence | 1999 |
Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii.
Topics: Adenosine Triphosphate; Animals; Antifungal Agents; Atovaquone; Dose-Response Relationship, Drug; Male; Naphthoquinones; Pentamidine; Pneumocystis; Pneumocystis Infections; Rats; Rats, Inbred BN; Rats, Long-Evans | 2000 |
Optimizing PCP therapy.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Encephalitis; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Anti-Infective Agents; Atovaquone; Dihydropteroate Synthase; Drug Resistance, Fungal; Fungal Proteins; Humans; Lymphoma, AIDS-Related; Male; Membrane Glycoproteins; Middle Aged; Mutation; Naphthoquinones; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; CD4 Lymphocyte Count; Cost-Benefit Analysis; Dapsone; Drug Costs; Humans; Life Expectancy; Models, Theoretical; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Quality-Adjusted Life Years | 2002 |
Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies.
Topics: Animals; Chagas Disease; Humans; Naphthoquinones; Pentamidine; Propolis; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Evaluation on the leishmanicidal activity of 2-N,N'-dialkylamino-1,4-naphthoquinone derivatives.
Topics: Animals; Antiprotozoal Agents; Inhibitory Concentration 50; Leishmania mexicana; Macrophages, Peritoneal; Mice; Naphthoquinones; Pentamidine | 2017 |